Verified Nov 2026
Other
·
Ballerup, Capital Region of Denmark
·
Since 1908
LEO Pharma is a multinational pharmaceutical company headquartered in Ballerup, Denmark, founded in 1908. With 1,000 to 5,000 employees and an estimated revenue of $1–5 billion, the company is privately owned by the LEO Foundation. It develops treatments for dermatology, thrombosis, and bone remodeling, serving patients across 100 to 130 countries. Recent approvals include Anzupgo® cream for chronic hand eczema in China and FDA priority review for dersimelagon.
LEO Pharma at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
1908
Headquarters
Ballerup, Capital Region of Denmark
Certifications
ISO 14001 · ISO 45001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
STABILITY SIGNALS
Established & active
118 years in operation (founded 1908).
Holds ISO 14001, ISO 45001 certification(s) per public sources.
Overview
LEO Pharma is a multinational pharmaceutical company headquartered in Ballerup, Denmark, founded in 1908. With 1,000 to 5,000 employees and an estimated revenue of $1–5 billion, the company is privately owned by the LEO Foundation. It develops treatments for dermatology, thrombosis, and bone remodeling, serving patients across 100 to 130 countries. Recent approvals include Anzupgo® cream for chronic hand eczema in China and FDA priority review for dersimelagon.
At a glance
Attribute | Detail |
|---|---|
Founded | 1908 |
Headquarters | Ballerup, Capital Region of Denmark |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 · ISO 45001 |
What LEO Pharma makes
The company develops biologics and topical treatments for conditions including psoriasis, eczema, and atopic dermatitis, and holds ISO 14001 and ISO 45001 certifications.
Products and capabilities described on the company's own site include LED (source: leo-pharma.com).
Certifications
LEO Pharma is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — leo-pharma.com
ISO 45001 — leo-pharma.com
Latest developments
2026-11-13 — LEO Pharma announces NMPA-approval of Anzupgo® (delgocitinib) cream for patients with moderate to severe chronic hand eczema (CHE) in China (businesswire.com)
2026-09-18 — LEO Pharma announces FDA acceptance of dersimelagon NDA with Priority Review and closes acquisition from Tanabe Pharma - LEO Pharma Global (leo-pharma.com)
2026-08-18 — LEO Pharma delivers 10% revenue growth at CER and strengthens late-stage pipeline - LEO Pharma Global (leo-pharma.com)
2026-04-30 — LEO Pharma bolsters rare skin disease focus through acquisition of Replay gene therapy platform - LEO Pharma (leo-pharma.com)
2026-04-14 — Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Esophageal Cancers | santé log (santelog.com)
2026-04-10 — LEO Pharma acquires Spevigo rights, completes dermatology portfolio in Korea < Pharma < Article - Korea Biomedical Review (koreabiomed.com)
Facilities
LEO Pharma is headquartered in Ballerup, Capital Region of Denmark. Public sources also reference these locations:
Denmark — leo-pharma.com
Company details
LEO Pharma operates as a private foundation-owned entity with approximately 4,000 to 6,000 employees and distributes its products across more than 100 countries. LEO Pharma was founded in 1908, has an estimated 1,000-5,000 employees, and is headquartered in Ballerup, Capital Region of Denmark. On the LightSource stability read it is rated "Established & active": 118 years in operation (founded 1908). Holds ISO 14001, ISO 45001 certification(s) per public sources.
Frequently asked questions
What does LEO Pharma do?
LEO Pharma is a multinational pharmaceutical company headquartered in Ballerup, Denmark, founded in 1908. With 1,000 to 5,000 employees and an estimated revenue of $1–5 billion, the company is privately owned by the LEO Foundation. It develops treatments for dermatology, thrombosis, and bone remodeling, serving patients across 100 to 130 countries. Recent approvals include Anzupgo® cream for chronic hand eczema in China and FDA priority review for dersimelagon.
Where is LEO Pharma headquartered?
LEO Pharma is headquartered in Ballerup, Capital Region of Denmark (55 Industriparken, Ballerup, Capital Region of Denmark, 2750).
When was LEO Pharma founded?
LEO Pharma was founded in 1908.
How big is LEO Pharma?
LEO Pharma has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
What certifications does LEO Pharma hold?
LEO Pharma lists ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
